Immediate Impact
59 standout
Citing Papers
H3K18 Lactylation Potentiates Immune Escape of Non–Small Cell Lung Cancer
2024 Standout
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
2024 Standout
Works of Franklin Chen being referenced
Avelumab (MSB0010718C; anti-PD-L1) as a first-line treatment for patients with advanced NSCLC from the JAVELIN Solid Tumor phase 1b trial: Safety, clinical activity, and PD-L1 expression.
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Franklin Chen | 150 | 299 | 98 | 108 | 17 | 513 | |
| Hajime Inoue | 81 | 190 | 121 | 56 | 22 | 637 | |
| Natalie Seiser | 120 | 180 | 95 | 105 | 11 | 553 | |
| Jin Xiong | 62 | 255 | 137 | 149 | 29 | 609 | |
| Jenny L. C. Geh | 146 | 234 | 64 | 82 | 29 | 565 | |
| Horst‐Dieter Becker | 221 | 341 | 81 | 36 | 16 | 507 | |
| Letizia Pieruzzi | 130 | 167 | 67 | 56 | 24 | 601 | |
| Sachin S. Vaikunth | 95 | 121 | 74 | 58 | 16 | 587 | |
| Teresa Pereda | 99 | 257 | 39 | 53 | 26 | 494 | |
| Hironobu Nakamura | 28 | 151 | 192 | 175 | 17 | 586 | |
| Hui-Chen Huang | 55 | 86 | 29 | 50 | 13 | 512 |
All Works
Loading papers...